Showing 231-240 of 19172 results for "".
The Benefits of TZDs for Early Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/the-benefits-of-tzds-for-early-type-2-diabetes/5343/Where do thiazolidinediones, or TZD's, fit in our clinical approach to treating patients with type 2 diabetes? TZD's used early in the course of the disease seem to be a powerful therapy with a substantial reduction in the progression of type 2 diabetes. What does this tell us about the pathogenesisNovel Therapies for Type 1 Diabetes
https://reachmd.com/programs/clinicians-roundtable/novel-therapies-for-type-1-diabetes/1767/How has Type 1 diabetes evolved in our society? When does the disease strike, and can we take preemptive action before it does? Dr. Ron Wilder, an internationally recognized rheumatologist and immunologist, speaks with host Dr. Danny Petrasek, addressing our ability to interfere with the disease phyType 1 Diabetes: Control and Cure
https://reachmd.com/programs/clinicians-roundtable/type-1-diabetes-control-and-cure/1771/Type 1 diabetes affects over 1 million Americans and costs billions of dollars every year. Dr. Denise L. Faustman, director of the Immunobiology Laboratories at the Massachusetts General Hospital in Boston, discusses with host Dr. Bruce Bloom her cure research and the possibility of a generic drug cType 2 Diabetes in Children and Adolescents
https://reachmd.com/programs/diabetes-discourse/type-2-diabetes-in-children-and-adolescents/5084/The emergence of type 2 diabetes in children and adolescents over the past 20 years represents a shift in pediatric chronic disease. Join host Dr. Steven Edelman and his guest, professor of pediatrics and director of the Children’s Diabetes and Endocrine Center of South Texas at Driscoll Children’sExploring Stem Cell Research & Novel Options in Type 1 Diabetes
https://reachmd.com/programs/diabetes-discourse/exploring-stem-cell-research-and-novel-options-in-diabetes/12273/Is there an alternative to insulin injections for patients with type 1 diabetes?Uncovering the Prevalence of Type 1 Diabetes in Older Adults
https://reachmd.com/programs/diabetes-discourse/uncovering-the-prevalence-of-type-1-diabetes-in-older-adults/17888/Treating older adults with type 1 diabetes requires proactive assessment and management strategies. Here are ways to improve outcomes in a population faced with increased complications.Supporting Patients with Type 1 Diabetes.
https://reachmd.com/programs/clinicians-roundtable/supporting-patients-with-type-1-diabetes/1106/What are the best practices in supporting a patient and their family in treating type 1 diabetes? How do you educate the family, How do you monitor the child? What is the physicians role in the management of a 24/7 disease. In this segment Dr. William Tamborlane shares his vast experience of caringSugary Drinks and the Increasing Epidemic of Type-2 Diabetes
https://reachmd.com/programs/clinicians-roundtable/sugary-drinks-and-the-increasing-epidemic-of-type-2-diabetes/6642/Host Dr. Farhad Zangeneh welcomes Dr. Anthony J. Cannon as they discuss the recently published studies that reviewed the association of sugary drinks, childhood obesity and epidemic increase of Type-2 diabetes. What are we doing? Are we getting better? And, ultimately, what we can be doing today, asDo We Already Have the Cure for Type 1 Diabetes?
https://reachmd.com/programs/focus-on-diabetes/do-we-already-have-the-cure-for-type-1-diabetes/3852/We spend billions each year to research possible cures for type I diabetes, but the cure may already be on the shelf. Join host Dr. Bruce Bloom and his guest, Dr. Denise L. Faustman, associated professor of medicine at Harvard Medical School and director of the Immunobiology Laboratories at MassachPrescribing Exercise for Patients with Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/prescribing-exercise-for-patients-with-type-2-diabetes/12093/How should clinicians go about prescribing exercise for patients with type 2 diabetes?